What the research shows about GLP-1 medications: According to a study published in the New England Journal of Medicine (STEP-1 trial), participants receiving once-weekly semaglutide 2.4 mg plus lifestyle intervention experienced a mean weight loss of 14.9% from baseline over 68 weeks, compared with 2.4% for placebo plus lifestyle intervention
Weight loss itself, regardless of how it is achieved, has also been associated with migraine improvement in patients with obesity, as supported by recent meta-analyses, though high quality RCT evidence remains limited, he told Healthline
Patients take ferrous sulfate at a dose of 325 milligrams once a day or once every other day together with a glass of orange juice or vitamin C to improve absorption at bedtime. New data shows that IV iron supplementation is extremely effective and can be particularly helpful for people with chronic iron deficiency, adds Avidan
95% CI, 0.75-0.98) among patients without cirrhosis at baseline
While occasional odor is normal, there are times when it might be a signal that your digestive system is struggling
What does it mean if society widely embraces injecting cadaver fat in the service of beauty
